Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome.
Neuroleptic-induced catatonia is reported in an adolescent patient who responded successfully to lorazepam. The authors propose five discrete stages toward the progression of neuroleptic malignant syndrome, each with a separate treatment.
Woodbury
M M
MM
Department of Psychiatry, Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Woodbury
M A
MA
D000293:Adolescent; D002389:Catatonia / Q000139:chemically induced* / Q000188:drug therapy / Q000523:psychology; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000523:psychology; D009460:Neurologic Examination / Q000187:drug effects; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D014268:Trifluoperazine / Q000009:adverse effects* / Q000627:therapeutic use
D014268:Trifluoperazine; D006220:Haloperidol; D008140:Lorazepam